Fig. 1.
Fig. 1. 8226/S myeloma cells adhered to FN have a survival advantage over nonadhered cells following acute doxorubicin exposure (A) but not following melphalan exposure (B) in cell growth based cytotoxicity assays. FN-adhered cells (---) were bound to FN-coated plates 24 hours before 1-hour drug exposure and control cells were grown in suspension (—). Response to doxorubicin was 12.6-fold lower in FN-adhered cells compared to nonadhered controls (IC50 values for adhered and nonadhered cells were of 4.85 × 10−7 mol/L and 8.5 × 10−8 mol/L, respectively). Data points are presented as cell viability determined by MTT cytotoxicity assay compared with untreated controls. Graphs are representative experiments that were repeated three times in replicates of four.

8226/S myeloma cells adhered to FN have a survival advantage over nonadhered cells following acute doxorubicin exposure (A) but not following melphalan exposure (B) in cell growth based cytotoxicity assays. FN-adhered cells (---) were bound to FN-coated plates 24 hours before 1-hour drug exposure and control cells were grown in suspension (—). Response to doxorubicin was 12.6-fold lower in FN-adhered cells compared to nonadhered controls (IC50 values for adhered and nonadhered cells were of 4.85 × 10−7 mol/L and 8.5 × 10−8 mol/L, respectively). Data points are presented as cell viability determined by MTT cytotoxicity assay compared with untreated controls. Graphs are representative experiments that were repeated three times in replicates of four.

Close Modal

or Create an Account

Close Modal
Close Modal